CCRM Nordic
CCRM Nordic is a Sweden-based non-profit providing commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products, serving biopharmaceutical and life sciences organizations developing advanced therapeutics.
- Company typePrivate
- Founded2023
- HeadquartersMölndal, Sweden
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CCRM Nordic does
CCRM Nordic is a Sweden-based non-profit organization founded in 2023 and headquartered in Mölndal. The organization provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products (ATMPs), targeting biopharmaceutical companies and research organizations developing advanced therapeutics. Its stated focus is on addressing computational limitations in drug discovery and therapeutic development by integrating quantum computing capabilities with AI-enhanced workflows for computational biology.
In December 2025, CCRM Nordic — alongside its affiliate CCRM — announced a strategic quantum-biotech collaboration with IonQ (IONQ) to develop AI-enhanced workflows for advanced therapeutics. The partnership is framed around accelerating therapeutic development processes through quantum compute combined with AI, addressing pain points around drug discovery workflows requiring specialized compute infrastructure.
CCRM Nordic operates as a non-profit with 11-50 employees and no publicly disclosed pricing, revenue model, or customer list. The available source material does not provide detail on funding sources, management team, office locations beyond the Mölndal HQ, certifications, or headcount trends. Product and service specifics are not enumerated beyond the high-level ATMP commercialization and development positioning and the AI/quantum workflow collaboration with IonQ.
CCRM Nordic firmographics
Firmographics- Name
- CCRM Nordic
- Website
- https://www.ccrmnordic.se
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CCRM Nordic is a Sweden-based non-profit providing commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products, serving biopharmaceutical and life sciences organizations developing advanced therapeutics.
- Ownership category
- akta.pro rank
CCRM Nordic industry classification
Industry- Product category
- Advanced Therapy Manufacturing Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM)
Keywords
Where CCRM Nordic is headquartered
LocationHeadquarters
- HQ city
- Mölndal
- HQ country
- Sweden
- HQ region
- Europe
Markets served
CCRM Nordic business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure
CCRM Nordic product offering
Product offeringCore offering
CCRM Nordic provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products. The organization supports biopharmaceutical companies and research organizations in developing and scaling advanced therapeutics, integrating quantum computing capabilities with AI-enhanced workflows for computational biology and drug discovery.
Product overview
Based on the available source data, no product or service information is available for CCRM Nordic. The sources provide only a loading/verification page and a news article mentioning CCRM Nordic in the context of a strategic partnership with IonQ for quantum-biotech collaboration on AI-enhanced workflows for advanced therapeutics.
Differentiator
Problem solved
Functional benefit
Products and services
- Advanced Therapy Commercialization Support
Companies that use CCRM Nordic
Customer profileSegments1 record
Ideal customer profiles1 record
CCRM Nordic technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
CCRM Nordic partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- IonQcoreCCRM Nordic and CCRM announced a quantum-biotech collaboration with IonQ to develop AI-enhanced workflows for advanced therapeutics. The partnership leverages IonQ's quantum computing capabilities combined with AI technologies to accelerate therapeutic development processes.
Recent moves1 record
Expansion highlights3 records
CCRM Nordic competitors and assessment
Company assessmentBroad incumbents
- IQVIA: Global life sciences services firm combining clinical, commercial, and real-world evidence capabilities. Relevant peer given CCRM Nordic's commercialization and development mandate for advanced therapeutics.
- Lonza: Global CDMO leader with a dedicated cell and gene therapies business unit. Sets the benchmark for ATMP process development and GMP manufacturing infrastructure that CCRM Nordic is building toward.
- Thermo Fisher Scientific (Pharma Services): Through its Patheon and Brammer Bio businesses, offers global development and manufacturing services for advanced therapies. Sets competitive pricing and capacity benchmarks for ATMP CDMOs.
- Catalent: Large global CDMO with significant cell therapy and biologics capabilities. Represents the scale and operational depth that newer entrants like CCRM Nordic must compete against for advanced therapy clients.
- Charles River Laboratories: Major CRO/CDMO offering preclinical and manufacturing services relevant to ATMP developers. Overlaps with CCRM Nordic in supporting therapeutic development workflows for biopharma clients.
Emerging players
- AGC Biologics: CDMO with growing cell and gene therapy service offerings and European facilities. A direct competitor for ATMP development and manufacturing contracts in Europe.
Regional players
- Recipharm: Swedish-headquartered CDMO with strong presence across the Nordics. Comparable as a regional ATMP-adjacent manufacturing and development services provider, though primarily a for-profit drug product CDMO.
- BICO (formerly CELLINK): Nordic-based life sciences company focused on bioprinting, cell line development, and lab automation. Comparable as a Nordic-headquartered life sciences infrastructure provider serving advanced therapy developers.
Direct peers
- CCRM (Centre for Commercialization of Regenerative Medicine): The parent/global entity with which CCRM Nordic shares branding and the IonQ quantum-biotech collaboration. Operates the same ATMP commercialization and development mission and provides the network from which CCRM Nordic draws its pipeline.
- Cell and Gene Therapy Catapult: UK-based non-profit accelerator offering development, manufacturing, and commercialization support for cell and gene therapies. Closest functional analog to CCRM Nordic in mission and operating model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
CCRM Nordic financial estimates
Financial estimateRevenue estimate
Valuation estimate
CCRM Nordic leadership team
Management profileNumber of profiles
CCRM Nordic funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CCRM Nordic M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CCRM Nordic
What does CCRM Nordic do?
CCRM Nordic provides commercialization support, development services, and manufacturing infrastructure for advanced therapy medicinal products. The organization supports biopharmaceutical companies and research organizations in developing and scaling advanced therapeutics, integrating quantum computing capabilities with AI-enhanced workflows for computational biology and drug discovery.
Is CCRM Nordic a public or private company?
CCRM Nordic is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CCRM Nordic founded?
CCRM Nordic was founded in 2023. It employs 11 to 50 people.
Where is CCRM Nordic based?
CCRM Nordic is headquartered in Mölndal, Sweden, in the Europe region.
Who are CCRM Nordic's main competitors?
Broad incumbents on record are IQVIA, Lonza, Thermo Fisher Scientific (Pharma Services), Catalent and Charles River Laboratories. AGC Biologics is listed as an emerging player. Regional players are Recipharm and BICO (formerly CELLINK). Direct peers are CCRM (Centre for Commercialization of Regenerative Medicine) and Cell and Gene Therapy Catapult.
Does CCRM Nordic have an API?
No public API is recorded for CCRM Nordic.
What industry is CCRM Nordic in?
CCRM Nordic's product category is Advanced Therapy Manufacturing Services. Its primary akta.pro industry code is HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 541714 and its SIC code is 8731.